Novartis AG
Market cap $263.6B
$140.92
NVS
$140.92
+1.60% today
Buy with €1M virtual cash · No real money
Novartis AG (NVS) is a publicly traded company listed on the XNYS. As of September 18, 2026, Invest's signal rates NVS a Hold, with the stock up 15% over the past year. You can practice trading NVS risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$263.6B
Volume
1.7M
52-wk High
$170.46
52-wk Low
$121.57
Day High
$141.21
Day Low
$139.97
Performance
1M
-8.8%
6M
-5.9%
1Y
+14.8%
Invest signal · NVS
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
NVS overview
AI overviewLatest NVS news
Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape
GlobeNewswire Inc. · 17h ago
Is Invesco S&P International Developed Quality ETF (IDHQ) a Strong ETF Right Now?
Zacks Investment Research · 1d ago
CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma Market Set for Expansion Through 2036, Fueled by Treatment Innovation and Rising Patient Demand
GlobeNewswire Inc. · 1d ago
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market Set for Strong Growth Through 2036, Driven by Next-Generation Innovation and Expanding Patient Access
GlobeNewswire Inc. · 1d ago
World’s largest vision award goes to Botond Roska and José-Alain Sahel
GlobeNewswire Inc. · 2d ago
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises.
The company sells its products globally, with the United States constituting close to one-third of total revenue.
Employees
75,267
30-Day Win Rate · NVS
12 days
11 days
Last 23 sessions
How to practice trading NVS
- 1
Use the NVS buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top NVS traders on Invest
Full leaderboardFrequently asked questions
Is NVS a good stock to buy right now?
As of September 18, 2026, Invest's signal rates NVS a Hold, based on its price trend, valuation, and fundamentals, with the stock up 15% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading NVS risk-free first.
What is Novartis AG's (NVS) market cap?
Novartis AG has a market capitalization of approximately $263.6B.
How has NVS stock performed?
NVS is up 15% over the past year and down 6% over six months. Its 52-week range runs roughly from $121.57 to $170.46. Past performance doesn't predict future results.
How can I practice trading NVS for free?
On Invest you get €1,000,000 in virtual cash and can buy NVS at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare NVS with peers